Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | FTI-277 |
| Synonyms | |
| Therapy Description |
FTI-277 is a farnesyltransferase inhibitor (FTI). Inhibition of farnesyltransferase blocks H-Ras and K-Ras processing and reduces proliferation in cancer cells (PMID: 7592920, PMID: 29627155). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| FTI-277 | Farnesyltransferase Inhibitor 4 | FTI-277 is a farnesyltransferase inhibitor (FTI). Inhibition of farnesyltransferase blocks H-Ras and K-Ras processing and reduces proliferation in cancer cells (PMID: 7592920, PMID: 29627155). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| HRAS wild-type | cancer | predicted - sensitive | FTI-277 | Preclinical | Actionable | In a preclinical study, the farnesyltransferase inhibitor FTI-277 sensitized Hras transformed rat fibroblasts to radiation therapy (PMID: 8620483). | 8620483 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|